MC
Cenerenti, Mara
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer | Science advances |  | 2025 | 86 | 188 | ||
| Unraveling cytotoxic tumor-specific CD4 T cells for advanced clinical applications |  | 2024 | 201 | 0 | |||
| Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | Cell | | 2024 | 965 | 262 | ||
| Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability | Frontiers in immunology | | 2023 | 114 | 57 | ||
| Dendritic cells direct circadian anti-tumour immune responses | Nature | | 2023 | 784 | 195 | ||
| The era of cytotoxic CD4 T cells | Frontiers in immunology | | 2022 | 213 | 246 | ||
| Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer | Science Advances | | 2021 | 495 | 335 | ||
| Impact of immunotherapy on CD4 T cell phenotypes and function in cancer | Vaccines | | 2021 | 256 | 158 |
